Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test

Neuropsychopharmacology - United Kingdom
doi 10.1038/sj.npp.1301535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Mouse Model of Down Syndrome Ts65Dn Presents Visual Deficits as Assessed by Pattern Visual Evoked Potentials

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Quantitative PCR Genotyping Assay for the Ts65Dn Mouse Model of Down Syndrome

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2003English

The Adult Ts65Dn Mouse Model of Down Syndrome Shows Altered Swallow Function

Frontiers in Neuroscience
Neuroscience
2019English

Developmentally Altered Inhibition in Ts65Dn, a Mouse Model of Down Syndrome

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2012English

Treatment of the Ppt1–/– Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis With the N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Memantine

Journal of Child Neurology
Child HealthNeurologyPediatricsPerinatology
2013English

Working Memory in the Aged Ts65Dn Mouse, a Model for Down Syndrome

Behavioural Brain Research
Behavioral Neuroscience
2012English

Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome

PLoS ONE
Multidisciplinary
2016English

Deleterious Effects of Chronic Folate Deficiency in the Ts65Dn Mouse Model of Down Syndrome

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2017English

Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome

Journal of Neuroscience
Neuroscience
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy